Demographic information (sex, age,) clinical and laboratory characteristics (HIT antibody titer, antiphospholipid antibody positivity, heparin exposure duration, baseline and nadir platelet counts, baseline and peak DDimer levels, confirmed thrombosis, secondary infections, procedures indicated and outcome) of the patients were described.